Last reviewed · How we verify
Lipid-lowering treatments — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Lipid-lowering treatments (Lipid-lowering treatments) — Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lipid-lowering treatments TARGET | Lipid-lowering treatments | Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lipid-lowering treatments CI watch — RSS
- Lipid-lowering treatments CI watch — Atom
- Lipid-lowering treatments CI watch — JSON
- Lipid-lowering treatments alone — RSS
Cite this brief
Drug Landscape (2026). Lipid-lowering treatments — Competitive Intelligence Brief. https://druglandscape.com/ci/lipid-lowering-treatments. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab